Iaboni, Andrea
Quirt, Hannah
Engell, Katia
Kirkham, Julia
Stewart, Steven
Grigorovich, Alisa
Kontos, Pia
McMurray, Josephine
Levy, AnneMarie
Bingham, Kathleen
Rodrigues, Kevin
Astell, Arlene
Flint, Alastair J.
Maxwell, Colleen
Funding for this research was provided by:
Province of Ontario Rapid Access COVID-19 research grant
Walter and Maria Schroeder Institute for Brain Innovation and Recovery
Department of Psychiatry, University of Toronto (Academic Scholars Award)
Canadian Consortium on Neurogeneration in Aging (Team 11, Neuropsychiatric Symptoms, Team 11, Neuropsychiatric Symptoms, Team 11, Neuropsychiatric Symptoms, Team 11, Neuropsychiatric Symptoms)
Article History
Received: 12 August 2021
Accepted: 5 January 2022
First Online: 25 January 2022
Declarations
:
: The study was approved by the University Health Network Research Ethics Board (REB#20-5866) and a University of Waterloo Research Ethics Committee (ORE#42803). All survey participants provided informed consent to participate by clicking a button that indicated they had reviewed the consent information and agreed to proceed to the survey.
: Not applicable.
: The author A.J. Flint discloses grant support from the U.S. National Institutes of Health, Patient-Centered Outcomes Research Institute, Canadian Institutes of Health Research, Brain Canada, Ontario Brain Institute, AGE-WELL, and the Canadian Foundation for Healthcare Improvement. The remaining authors have no conflicts of interest to report.